Life and health insurers have had to think about how to incorporate COVID-19 into medical underwriting, and benefit and product design. This paper discusses the current state of clinical understanding and research on the health implications of acute Covid and long Covid, along with the responses of health and life insurers in product design, underwriting, and claims management. Topics we discuss include: 

• A clinical perspective of acute and post-acute Covid
• Incidence and prevalence of long Covid
• Risk factors for long Covid
• Evolution of long Covid in hospitalized and non-hospitalized patients
• Implications for insurers
• A survey of European and Asian insurers